Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

在I期临床试验中，DOC1021展现出良好的安全性与显著的免疫激活效果：患者的一年生存率达到88%，远高于传统治疗约60%的水平，其中首位受试者在接种后超过两年依然存活。

Scientists have pinpointed a crucial network of immune cells that allows humans to digest food safely without triggering ...

The study aims to uncover the immunological basis of Tanshi (phlegm-dampness) constitution—a subhealth type in traditional Chinese medicine ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

Harvard Business School (HBS) has named its 2025-26 Blavatnik Fellows and the program’s twelfth cohort. Launched in 2013, the ...

The Business Research Company's Stem Cell Umbilical Cord Blood Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034) It will grow to $15.21 billion in 2029 at a compound annual ...